Does low estrogen signaling help drive a self-amplifying loop of chronic low-grade inflammation?

In postmenopausal biology, the decline in estrogen signaling acts as a primary trigger for a complex, self-amplifying network of chronic low-grade inflammation.

Estrogen-cytokine-iron axis

• Loss of estrogenic control: Estrogen normally acts as a physiological brake by inhibiting NF-κB activation and downstream cytokine transcription. Depleted estrogen levels remove this inhibition, leading to elevated expression of pro-inflammatory interleukin-6 (IL-6).
• Hepcidin-mediated iron trapping: Elevated systemic IL-6 drives the upregulation of hepcidin via the JAK/STAT3 signaling pathway. This induces inflammatory iron sequestration, trapping iron inside macrophages and parenchymal tissues.

Oxidative stress and cellular senescence

• Fenton reaction feedback: Sequestered intracellular iron acts as a potent catalyst for Fenton chemistry, generating highly reactive hydroxyl radicals. This resulting oxidative stress reactivates NF-κB, which further upregulates IL-6 production to close a pathogenic, self-sustaining loop.
• Antigenic contribution: In parallel, chronic antigenic stimulation from persistent exposures or immunosenescence acts as a plausible driver of this systemic state. It promotes T-cell senescent phenotypes and the senescence-associated secretory phenotype (SASP), releasing additional cytokines into the circulation.

Bottom line

• Estrogen deficiency, IL-6-driven signaling, iron sequestration, and oxidative stress form a tightly closed, self-reinforcing loop of chronic low-grade inflammation, with chronic antigenic stimulation acting as a plausible parallel contributor that sustains this pathogenic cycle.